CVE-2023-27929

Description

An out-of-bounds read was addressed with improved input validation. This issue is fixed in macOS Ventura 13.3, tvOS 16.4, iOS 16.4 and iPadOS 16.4, watchOS 9.4. Processing a maliciously crafted image may result in disclosure of process memory.

Category

5.5
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.04%
Vendor Advisory apple.com Vendor Advisory apple.com Vendor Advisory apple.com Vendor Advisory apple.com
Affected: Apple macOS
Affected: Apple iOS and iPadOS
Affected: Apple watchOS
Affected: Apple tvOS
Published at:
Updated at:

References

Link Tags
https://support.apple.com/en-us/HT213670 release notes vendor advisory
https://support.apple.com/en-us/HT213676 release notes vendor advisory
https://support.apple.com/en-us/HT213678 release notes vendor advisory
https://support.apple.com/en-us/HT213674 release notes vendor advisory

Frequently Asked Questions

What is the severity of CVE-2023-27929?
CVE-2023-27929 has been scored as a medium severity vulnerability.
How to fix CVE-2023-27929?
To fix CVE-2023-27929, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-27929 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-27929 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-27929?
CVE-2023-27929 affects Apple macOS, Apple iOS and iPadOS, Apple watchOS, Apple tvOS.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.